Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: Implications for prevention and therapy

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2177-2185

  Fernandez Pol, J Albert ^a,b,c  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Growth factors; Metallopanstimulin; Oncogenesis; Ribosomal proteins; Tumor markers; Zinc finger proteins

Indexed keywords

TUMOR MARKER; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOASSAY; SERUM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASE SEQUENCE; FEMALE; HUMANS; MALE; METALLOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASMS; NUCLEAR PROTEINS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL; ZINC FINGERS;

EID: 0029789360     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fernandez-Pol JA, Klos DJ, and Hamilton PD: A Growth Factor-inducible gene encodes a novel nuclear protein with zinc-finger structure. J Biol Chem 268: 21198-21204, 1993.
2. Fernandcz-Pol JA, Klos DJ and Hamilton PD:. Metallopanstimulin gene product produced in a Baculovirus expression system is a nuclear phosphoprotein that binds to DNA. Cell Growth & Differentiation 5: 811-825, 1994.
3. Xynos FP, Klos DJ, Hamilton PD, Schuette V, Huygens P, and Fernandez-Pol JA: Expression of Metallopanstimulin in Condylomata Acuminata of the Female Anogenital Region Induced by Papilloma Virus. Anticancer Research, 14: 773-786, 1994.
4. Fernandez-Pol JA: Metallopanstimulin is a multifunctional ribosomal protein relevant to numerous oncogenic processes which can be used as a ubiquitous tumor marker in various clinical assays. In: Geriatric Oncology (Balducci L, Lyman GH, Henderson CC, and Ershler, WB, eds), Harwood Academic Publishers, in press. 1996.
5. Chan Y-L, Suzuki K, Olvera J, Wool IG: Zinc finger-like motifs in rat ribosomal proteins S27 and S29. Nuc Acids Res 21: 649-655, 1993.
6. Santa Cruz DJ, Klos DJ, Hamilton PD and Fernandez-Pol JA: The expression of metallopanstimulin (MPS-1) in melanocytic lesions. Submitted for publication, 1996.
7. Fernandez-Pol JA, Klos DJ, and Hamilton PD: Radioimmunoassay of circulating MPS-1 protein. Submitted for publication, 1996.
8. Grant GA (ed.): Synthetic Peptides. WH Freeman and Co., New York, 1992, pp. 1-366.
9. Fernandez-Pol JA, Klos DJ, and Hamilton, PD: The Evaluation of Metallopanstimulin as a novel tumor marker in sera of patients with prostatic carcinoma. European J of Nuclear Medicine, Supp. Vol. 21, No. 10, pS94 (Abs. 368), 1994.
10. Fernandez-Pol JA and Klos DJ: Metallopanstimulin as a novel tumor marker in sera of patients with prostatic carcinoma. J. Tumor Marker Oncology 10: 54 (Abs. 49), 1995.
11. Fernandez-Pol JA, Klos, DJ, and Hamilton. PD: The evaluation of Metallopanstimulin as a tumor marker in sera of patients with various types of tumors. Submitted for publication. 1996.
12. Sackett DL, Haynes RB, Guyatt GH, Tugwell P: Clinical Epidemiology: A basic science for clinical medicine: second edition. Little, Brown and Co., Boston, Toronto, London. 1991, pp. 69-185.
13. Assessing the Quality of Radioimmunoassay Systems- Second Edition: Approved Guideline. NCCLS document LA1-A2; Vol. 14 No. 17(ISBN 1-56238-250-0), December 1994, pp 1-23. NCCLS, 771 East Lancaster Ave., Villanova. PA 19085.
14. Schwartz, M.K.: Cancer Markers. In: Cancer: Principles and Practice of Oncology (DeVita Jr, VT, Hellman S, and Rosenberg SA, eds). Philadelphia, J.B. Lippincott Co, 4th Ed. Vol. 1, 1993, pp. 531-542.
15. Klavins, JV, Birkmayer, GD, and Pimentel, E (eds): 12th International Conference on human tumor markers, J. Tumor Marker Oncology 10 (No.2): 27-92, 1995.
16. Klapdor, R (ed): Abstracts of the eighth international Hamburg symposium on tumor markers. Anticancer Research 15 No. 6A: 2371-2451, 1995.
17. Sliutz G, Tempfer C, Kainz CH, Mustafa G, Gitsch G, Koelbl H and Biegelmayer CH: Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer. Anticancer Research 15: 1127-1130, 1995.
18. Luo J-C, Zehab R, Anttila S, Ridanpaa M, Husgafvel-Pursiainen K, Vainio H, Carney W, DeVivo I, Milling C and Brant-Rauf P: Detection of serum p53 protein in lung cancer patients. JOM 36: 155-160, 1994.
19. Kozwich DL, Kramer LC, Mielicki WP, Fotopoulos SS and Gordon SG: Application of cancer procoagulant as an early detection tumor marker. Cancer, 74: 1367-1376, 1994.
20. Grazi GL, Mazziotti A, Legnani C, Jovine E, Minicro R, Gallucci A, Palareti G and Gozzetti G: The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. Liver Transplantation and Surgery 1: 249-255, 1995.
21. Abelev GI, Perova SD, Khramkova NI: Production of embryonal alpha-globulin by transplantable mouse hepatoma. Transplantation 1: 174-180. 1963.
22. Gold P and Freeman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467-481, 1065.
23. Brawer, MK, Chetner MP, Beatie, J, Buchner DM, Vessella. RL, and Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J of Urology, 147: 841-845, 1992.